Atlas Trials

Acral Lentiginous Melanoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acral Lentiginous Melanoma

RecordFirmDate
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases (NCT04511013)SWOG Cancer Research Network2021-01-06
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies (NCT04244552)Atreca, Inc.2020-02-11
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (NCT03698019)National Cancer Institute (NCI)2019-02-15
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease (NCT03025256)M.D. Anderson Cancer Center2018-05-02
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab (NCT02978443)Georgetown University2017-07-26
Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma (NCT02875132)Chinese University of Hong Kong2017-02-15
Dinaciclib in Treating Patients With Stage IV Melanoma (NCT00937937)National Cancer Institute (NCI)2009-07-01
Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma (NCT00424515)Dana-Farber Cancer Institute2006-07-01

Track Acral Lentiginous Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.